APA (7th ed.) Citation

DW, O., KG, L., MC, S., EP, I., LO, W., SR, C., . . . AE, W. (2022). Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA, 328(2), 151. https://doi.org/10.1001/jama.2022.9805

Chicago Style (17th ed.) Citation

DW, Oslin, et al. "Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial." JAMA 328, no. 2 (2022): 151. https://doi.org/10.1001/jama.2022.9805.

MLA (9th ed.) Citation

DW, Oslin, et al. "Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial." JAMA, vol. 328, no. 2, 2022, p. 151, https://doi.org/10.1001/jama.2022.9805.